Spermine inhibition of monocyte activation and inflammation

M Zhang1, L V Borovikova, H Wang

  • 1The Picower Institute for Medical Research, Manhasset, New York 11030, USA. mzhang@picower.edu

Insights

Spermine, a natural compound, limits the innate immune response by reducing inflammatory cytokine production in monocytes. This mechanism is crucial for preventing excessive tissue damage during inflammation and in tumors.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • The innate immune system, including monocytes and macrophages, protects against pathogens but can cause collateral tissue damage through proinflammatory mediators like TNF and NO.
  • Anti-inflammatory mediators are essential for controlling innate immune responses and preventing excessive tissue injury.
  • Spermine, a biogenic polyamine, is known to suppress monocyte proinflammatory cytokine synthesis, potentially acting as a counterregulatory mechanism in conditions like infection, injury, and tumors.

Purpose of the Study:

  • To investigate the role of spermine uptake in monocyte deactivation.
  • To elucidate the mechanism by which spermine inhibits monocyte proinflammatory cytokine synthesis.
  • To determine the in vivo relevance of spermine-mediated inhibition of innate immune responses.

Main Methods:

  • Monocyte spermine uptake was measured following lipopolysaccharide (LPS) stimulation.
  • The polyamine analogue 1,4-bis(3-aminopropyl)-piperazine (BAP) was used to inhibit spermine uptake.
  • Macrophage TNF synthesis was assessed in the presence of spermine and BAP.
  • Carrageenan-induced paw edema and nitric oxide release were measured in vivo following BAP administration.

Main Results:

  • Monocyte spermine uptake significantly increased after LPS stimulation.
  • BAP inhibited LPS-stimulated monocyte spermine uptake, indicating the involvement of a nonselective polyamine transporter.
  • BAP treatment restored macrophage TNF synthesis despite the presence of spermine, confirming that spermine's deactivating effect depends on its uptake.
  • In vivo administration of BAP enhanced carrageenan-induced paw edema and nitric oxide release.

Conclusions:

  • Endogenous spermine normally inhibits the innate inflammatory response by suppressing macrophage activation.
  • Spermine's inhibitory effect on monocytes is dependent on its cellular uptake via a nonselective polyamine transporter.
  • Targeting spermine uptake represents a potential strategy for modulating inflammatory responses.